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RECENT experiments with V79 Chinese
hamster cells in vitro (Stratford and
Adams, 1977) have shown that the 2-
nitroimidazole Ro-07-0582 (Roche Pro-
ducts, Welwyn Garden City, Herts) is
considerably more cytotoxic to hypoxic
cells than to well-oxygenated ones. In
addition, this differential effect is pro-
gressively enhanced by increases in tem-
perature which, in themselves, cause little
cell killing. The aim ofthe present study
was to determine whether this differential
cytotoxicity could also be demonstrated
in a solid tumour in vivo.
On the basis ofthese in vitroresults, we
anticipated that the hypoxic cells in the
tumour under investigation would be
more sensitive than the oxic cells to the
cytotoxic action of Ro-07-0582, and thus
the tumours were first exposed to a single
dose of X-rays to kill the radiosensitive
oxic cells, and then the drug was admini-
stered. In an attempt to demonstrate
increased cytotoxicity to the hypoxic cells,
the tumours were then heated. It was
essential to give the drug after irradiation
to avoid radiosensitization of the hypoxic
cells (Asquith et al., 1974; Denekamp,
Michael and Harris, 1974), which would, of
course, mask the drug's cytotoxic action.
The tumour used in these experiments
was derived from a serially transplanted
fibrosarcoma which arose spontaneously
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in Dr H. B. Hewitt's WHT mouse colony
at the Gray Laboratory. An in vitro cell
culture was established from one of these
tumours and, after a period of adaptation
to the in vitro growth conditions, the cells
of this new line, denoted Fib/T, would
form colonies with a plating efficiency of
60-90% when plated on to a "feeder
layer " of cells killed by radiation. Sub-
cutaneous injection of 105 or more ofthese
cultured cells into a mouse resulted in a
palpable tumour within 7 to 14 days. This
tumour was excised when it had reached a
diameter of about 8 mm (mean of 3
dimensions) and approximately 1-mm3
pieces of tumour were implanted s.c. by
trocar on to the chests of up to 100 male
WHT mice to provide the experimental
tumours. The cells of these tumours, if
plated in vitro in appropriate conditions,
form colonies with a plating efficiency,
like the parental cell line, of 60 to 9000.
When the experimental tumours had
reached a mean diameter of 8 mm they
were distributed randomly between con-
trol groups and groups receiving com-
binations of heat, Ro-07-0582 and X-rays
(Table). Tumours were irradiated in air
with single doses of 240 kV X-rays as
described by Fowler et al. (1975). The
drug, at a dose of 1 mg/g body wt., was
administered by i.p. injection immediately
after irradiation, and heating was begun
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TABLE-The Number ofTumours Receiving
the Different treatments
X-ray close krad
Treatment 0 1 1
0 0 5 1-0 1-5 2-5
X-rays only 14 2 2 4 2
Ro-07-0582 1 mg/g i.p. 2 2 2 3 2
Heat 40 5°C, 1 h 2 2 2 3 2
Ro-07-0582 plus Heat 2 2 4 4 2
Each tumour used represents a single estimate of
the surviving fraction. These values were pooled to
construct the survival curves in Fig. 1.
exactly 10 min later. Tumours were
heated by laying the anaesthetized mice
horizontally in Perspex jigs with holes in
them, so that the tumours (as well as part
of the ventral surface of the animals)
could protrude downwards so that they
were fully immersed in the water bath.
By this method the centre of the tumours
reached a temperature of 40 5 ± 0 2°C at
a waterbath temperature of 41-0 ± 0.2°C.
Initially, the temperature of the tumours
wasmeasuredbyathermocoupleimplanted
into the centre of the tumour, either
externally, in which case a small part of
the sensor was exposed to the waterbath,
or by inserting it s.c. above the water
level and threading it down into the
tumour from above. The difference in
the readings obtained by the 2 methods
was small (less than 0.2°C) so the more
simple, external method was adopted in
all the experiments reported here. In
the first experiment a tumour core
temperature of 40.50C, measured as indi-
cated above, was maintained for 1 h.
In all cases including the " untreated "
controls, the animals were anaesthetized
with pentobarbitone sodium. An initial
i.p. injection of 60 mg/kg was given (10%
less for animals treated with the drug)
and additional doses of 20 mg/kg were
used to maintain anaesthesia.
Immediately after the heat treatment,
the mice were killed by neck luxation and
their tumours excised. Suspensions of
cells were prepared as described by
McNally (1972) and a known number of
cells were transferred in alpha medium
(Flow Laboratories) with 15% foetal calf
serum and antibiotics to 50-mm Petri
dishes each containing 5 x 104 " feeder "
cells. Four or 8 dishes (i.e. one or 2
dilutions of the tumour cells) were pre-
pared for each tumour. They were then
incubated for 8 to 10 days at 37°C in a
humidified atmosphere of 5% C02 in air.
Thecolonieswerethenstainedandcounted,
and the surviving fractions calculated.
The results are shown in Fig. 1. The
surviving fraction is plotted against X-ray
dose for each of 4 treatment groups.
Each point represents the pooled results
from between 2 and 4 tumours (see Table).
Error bars are the standard errors of the
mean. The surviving fractions for treat-
ments with X-rays plus drug (without
heat) and for X-rays plus heat (without
drug) were not significantly different from
those for treatments with X-rays alone,
although in almost all cases the points fell
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Fie. 1. Surviving fraction of Fib/T tumour
cells vs X-ray dose for different treatments.
x, X-rays only; A, X-rays followed by 1 h
heating at 40 5°C (tumour core); 0, X-rays
followed by i.p. injection of Ro-07-0582
(1 mg/g); 0, X-rays followed by Ro-07-
0582 (1 mg/g) and heat (1 h at 40.5°C).
Each point represents the pooled results
from between 2 and 4 tumours (see Table)
and the bars show the s.e. mean.
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below the X-ray survival curve in Fig. 1.
By contrast, the curve for the combined
treatment of X-rays followed by heat plus
the drug was significantly lower than
those for the other treatments. The
addition of the heat plus the drug after
irradiation reduced the X-ray dose neces-
sary to give a surviving fraction of 10-2 by
780 rad. Fig. 1 shows that all the curves
were parallel over the range of X-ray
doses used, from 0 to 2500 rad, implying
that the combination ofheat plus the drug
was just as effective in killing cells in the
un-irradiated tumours as in killing those
surviving different X-ray doses. This is
probably due to the high hypoxic fraction
in this tumour, at least 50% (McNally,
unpublished data).
Recent experiments with this tumour
have shown that the maximum radio-
sensitization by Ro-07-0582 given prior to
irradiation is not achieved until 45-60 min
after an i.p. injection, and persists at a
maximum for a further hour (McNally,
unpublished data). In view of this, in a
second experiment, tumours were heated
for 1, 2 or 4 h with or without an injection
of Ro-07-0582. In this experiment tum-
ours were not irradiated first, since the
additional fraction of cells killed by heat
plus the drug was very similar at all X-ray
doses (Fig. 1).
The fraction of cells surviving after
heat alone, Ro-07-0582 alone, or a com-
bination ofthe two, is plotted against time
of heating after injection of the drug in
Fig. 2. The values obtained for indivi-
dual tumours are shown as separate points.
In the case of heat alone, there was no
significant increase in cell killing with
time. Contact with the drug alone for
1 or 2 h had no effect, but after 4h the
surviving fraction was reduced to about
0-5. The effect of the combined treat-
ment ofheat plus the drug did not change
with time after 1 h ofheating, although at
1 and 2 h it was considerably more
effective than either treatment alone or
the sum of the two, implying interaction
between the two forms oftreatment. This
means an enhancement of the cytotoxic
action of Ro-07-0582, since heat itself had
no effect. By 4 h, however, the cytotoxic
action of the drug alone had become
significant. This meant that the com-
bined effect of the drug and heat at 4 h
was no different from the sum of the
effects of the two acting independently.
The absence of any further interaction at
4 h is probably a reflection of the falling
concentration ofRo-07-0582 in the tumour
(see below).
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FIG. 2.-Surviving fraction of Fib/T tumour
cells as a function of the time of treatment
in vivo before excision of the tumour.
The values for individual tumours are
shown as separate points. 0 - 0,
1 mg/g Ro-07-0582 injected at t - o.
A --- A, Tumour heated at 4050C.
- .*- , 1 mg/g Ro-07-0582 injected at
t 0 immediately followed by heating the
tumour to 40-5°C.
The response of the tumours to heat
alone is consistent with the findings of
Har-Kedar (personal communication) and
of Palzer and Heidelberger (1973), who
showed that temperatures below 42°C are
not effective in killing mammalian cells
in vitro. The results shown in Figs. 1
and 2 clearly demonstrate that, while the
heat in itself had no effect, it greatly
enhanced the cytotoxic action of Ro-07-
0582 on the hypoxic tumour cells. The
enhancement seen at 1 h is in good agree-
ment with the in vitro results of Stratford
and Adams (1977). Increasing the time
ofheating from 1 to 4 h, however, did not
increase this enhancement. This is in
apparent contrast to the results of Strat-
374HYPERTHERMIA AND RADIOSENSITIZER IN SOLID TUMOUR 375
ford and Adams (1977) who found that,
over the same time period, the cytotoxic
effect of Ro-07-0582 at a concentration
of 0-2 mg/ml on hypoxic cells maintained
at 41°C in vitro was increased by a factor
of 100.
A possible explanation for this dis-
crepancy is as follows. An artificially
high value for cell survival in the tumour
would result if those cells destined to be
non-survivors because of the treatment
were selectively removed, either before
the tumour was excised or during the
preparation of the cell suspension. The
mean cell yield per gram of tumour was
approximately 50% less after 4 h treat-
ment in the presence ofthe drug than after
any of the other treatments. However,
this difference was not significant and,
since this tumour has such a high hypoxic
fraction, this explanation probably cannot
explain the discrepancy with the in vitro
results. A second and more likely explana-
tion for the apparent discrepancies with
the in vitro results, as indicated previously,
is that by 1P5 to 2 h after injection of the
drug, its concentration in the tumour was
probably too low to expect further
significant interaction with the hyper-
thermia.
Bleehen, Honess and Morgan (1977)
have been carrying out similar experi-
ments to us, using the EMT6 tumour, in
which they also assay cell survival in
vitro after treatment in vivo. They did
not irradiate the tumours before heating.
They obtained tumour core temperatures
in the range 40 5 to 43°C. A tumour
temperature of 40 5°C for 1 h produced
the same amount of cell killing in the
EMT6 tumour as it did in the Fib/T
tumour. However, in contrast to our
results, Bleehen et al. (1977) found little
interaction of the hyperthermia with
Ro-07-0582 (used at the same concen-
tration as in the present experiments)
below a tumour core temperature of about
42-5WC. This difference may reflect the
different hypoxic fractions in the two
tumours, > 50% in the Fib/T tumour,
about 30% in the EMT6 tumour.
In summary, an appreciable enhance-
ment ofthe cytotoxic action ofRo-07-0582
on hypoxic tumour cells in vivo was
observed within 1 h ofheating at 40*5°C, a
temperature which, by itself, had no
effect. This enhancement was not in-
creased by increasing the time of heating
to 4 h. In contrast, if it were possible to
make use of the interaction of mild
hyperthermia and Ro-07-0582 in the
treatment of human tumours, one might
expect that increasing the duration of the
hyperthermia would greatly enhance the
drug's cytotoxic action in these tumours.
This is because of its much longer half-life
in man than in the mouse (Gray et al.,
1976). In this respect the mouse is a poor
model of the clinical situation.
We thank Dr J. F. Fowler for helpful
discussions, and Miss A. Walder, Miss A.
Marriott and Mrs S. Bull for production
and care of the animals.
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